Dec 28 (Reuters) - Regeneus Ltd (RGS) Seeks trading halt to enable co to complete signing of transaction documents regarding entry into strategic collaboration and licensing agreement for Progenza Stem Cell Technology in Japan
Week 48 Wrap: ASX flirts with 8,500pts; APRA declines mortgage loan easing; Trump's Bessent tied to Dem donor
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
